Carlos Beltran Buendia

Statistics

Publications

Citations

740

H-Index

Active since

2004

Affiliations

Hospital Barros Luco-Trudeau(Current)

Research Triangle Park Foundation

GlaxoSmithKline (United States)

Carlos Beltran Buendia is an author at Hospital Barros Luco-Trudeau specializing in hiv antiretroviral therapy, antiretroviral therapy, and antiviral agents.

Publications per year

2004–2013

Publications

Dolutegravir versus raltegravir in antiretroviral-experienced, integrase-inhibitor-naive adults with HIV: week 48 results from the randomised, double-blind, non-inferiority SAILING study

Pedro Cahn, Anton Pozniak, Horacio Mingrone et al. · The Lancet · 2013 · 514 citations · Full text

Pharmacy, Clinical Pharmacokinetics, Pharmacotherapy +16

Abacavir versus Zidovudine Combined with Lamivudine and Efavirenz, for the Treatment of Antiretroviral‐Naive HIV‐Infected Adults

Edwin DeJesus, Gisela Herrera, Eugénio Teófilo et al. · Clinical Infectious Diseases · 2004 · 226 citations · Full text

Medicine, Pharmacology, Pharmacotherapy +17

1–2 of 2